Naproxen Emo Bausch Health Ireland Limited (Naproxen)

The naproxen in Naproxen Emo blocks cyclooxygenase (COX‑1 and COX‑2) enzymes in the skin, which lowers the production of prostaglandins—chemical messengers that cause pain, swelling, and fever. By reducing prostaglandin levels locally, the product diminishes inflammation and alleviates pain at the site of application.

The appropriate amount of Naproxen Emo is determined by the prescribing healthcare professional based on the severity of symptoms, the area to be treated, and individual patient factors. Patients should follow the prescriber’s instructions and the product label for the correct amount and frequency of application.

Safety of topical naproxen during pregnancy or lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this product.

To request Naproxen Emo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Naproxen Emo delivers the active ingredient directly to the skin, offering localized relief with lower systemic exposure compared with oral tablets. This can reduce the risk of gastrointestinal side effects common with oral NSAIDs, but it is intended for surface‑level pain rather than widespread systemic pain control.

Store Naproxen Emo at temperatures below 25 °C in its original packaging. Keep the container tightly closed, protect it from moisture, heat, and direct sunlight. Do not freeze the product, and keep it out of reach of children.

Apply a thin layer of the product to clean, dry skin over the painful or inflamed area. Gently rub it in until it disappears, usually 2–3 times daily or as directed by a healthcare professional. Avoid covering the treated area with occlusive dressings unless advised.

Serious risks include severe allergic reactions such as swelling, hives, or difficulty breathing, and rare cases of systemic NSAID effects like gastrointestinal bleeding if significant absorption occurs. Users should stop the product and seek immediate medical attention if any signs of a serious reaction appear.

Individuals with known hypersensitivity to naproxen, other NSAIDs, or any component of the formulation should avoid using the product. It should also be avoided on broken, infected, or severely irritated skin, and caution is advised for patients with severe renal, hepatic, or cardiovascular conditions unless cleared by a physician.